Enliven Therapeutics shares owned by Swiss National Bank
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Swiss National Bank
from 13F filings
Historical chart of Swiss National Bank investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Swiss National Bank
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.3M | 63k | 20.47 |
| 2025-06-30 | $1.2M | 62k | 20.06 |
| 2025-03-31 | $824k | 42k | 19.68 |
| 2024-12-31 | $942k | 42k | 22.50 |
| 2024-09-30 | $939k | 37k | 25.54 |
| 2024-06-30 | $859k | 37k | 23.37 |
| 2024-03-31 | $647k | 37k | 17.59 |
| 2023-12-31 | $505k | 37k | 13.84 |
| 2023-09-30 | $556k | 41k | 13.66 |
| 2023-06-30 | $1.0M | 49k | 20.41 |